PATH240628C13500
- 0.01
- 0.000.00%
UiPath Newsroom
UiPath (PATH) Gets a Hold From Wells Fargo
UiPath Analyst Ratings
BMO Capital lowered UiPath's target price to $14.
UiPath Analyst Ratings
BMO Capital Maintains Market Perform on UiPath, Lowers Price Target to $14
Macquarie Downgrades UiPath to Neutral From Outperform, Adjusts Price Target to $12 From $29
Analysts Offer Insights on Technology Companies: UiPath (PATH) and MongoDB (MDB)
Canadian Investment Banking Group: Maintaining the UiPath (PATH.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $30.00 to $19.00.
UiPath Analyst Ratings
Canaccord Genuity Maintains Buy on UiPath, Lowers Price Target to $19
Analysts Offer Insights on Technology Companies: Enphase Energy (ENPH) and UiPath (PATH)
JP Morgan Maintains Overweight on UiPath, Lowers Price Target to $19
UiPath Analyst Ratings
Evercore ISI Group: Maintaining the UiPath (PATH.US) rating, adjusted from the market to the simultaneous market rating, and the target price was adjusted from $27.00 to $13.00.
William Blair: Downgraded the UiPath (PATH.US) rating from superior to market to consistent market rating.
UiPath Receives Swath of Downgrades Following Soft Earnings, Abrupt CEO Change
Analysts Offer Insights on Technology Companies: Salesforce (CRM), Credo Technology Group Holding Ltd (CRDO) and UiPath (PATH)
UiPath Inc: Bank of America Global Research cuts from buying to neutral; cuts target price from $30 to $16
RBC Cuts Price Target on UiPath to $19 From $24, Notes 'Execution Issues,' CEO Transition, Keeps Sector Perform Rating
Maintaining Neutral on UiPath Amidst Revised Forecasts and Management Changes